Navigation Links
BIT Group Executive Featured in BioTechnology Series

Richard Henson, CEO of Source Scientific, LLC (a BIT Group Company) proffered his views of outsourcing product development trends as they pertain to the design and manufacture of diagnostic instrumentation in a recent interview by BIOCOM, the largest regional life science association in the world.

Irvine, CA, USA (PRWEB) June 23, 2010 -- BIT Group has revealed that Richard Henson, CEO of Source Scientific, LLC, ( a BIT Group Company located in Irvine, California) was recently selected to share his views regarding upcoming trends in diagnostic product development with BIOCOM, the largest regional life science association in the world. BIOCOM's series VIEW FROM THE TOP delivers the latest biotechnology industry knowledge and market insight through cutting-edge, video-driven interviews featuring top biotech executives.

The interview with Richard Henson covers the growing complexity of medical instrumentation and the role of outsourcing product development amidst the challenges of new and emerging technologies and increasingly complex regulatory requirements. According to Mr. Henson, because Source Scientific designs and manufactures systems for the clinical chemistry market as well as for therapeutic and other medical and diagnostic technology markets, he has gained an insight into upcoming challenges presented by increasingly sophisticated biotechnical advances. Mr. Henson asserts that because medical and diagnostic instrumentation is growing ever more complex, the competencies needed to produce this equipment are becoming more unique and multifaceted. "Medical companies look to qualified suppliers such as Source Scientific to provide the brain power and specialized experience necessary to design and manufacture such high-tech devices." A complete airing of Mr. Henson's interview may be found at

Source Scientific provides device / instrument contract product development, manufacturing and after-sales service to medical and diagnostic clients, specializing in complex medical and IVD instrumentation. Source Scientific / BIT Group offer systems solutions worldwide, adhering to FDA, ISO13485 and 9001 standards. Source Scientific, based in Irvine, CA, provides the US medical device / IVD industry with a localized source for instrument contract product development, manufacturing and after-sales service.

For more than 35 years, BIT Group has provided instrument contract product development, manufacturing and after-sale services to medical, diagnostic, and bio-technology clients. As part of the financially-strong Messer Group, BIT Group offers its systems solutions worldwide and with adher-ence to ISO13485 and 9001 standards. As a FDA registered contract service provider, BIT Group meets the high standard of medical product regulation, meeting design-to-cost and time-to-market targets.

BIT Group Companies include Source Scientific, LLC in Irvine, CA, USA , BIT Analytical Instruments, Inc. in Ludlow, MA, USA , BIT Analytical Instruments GmbH in Schwalbach, Germany and BIT CNC Machining in Kunshan, China.


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Avicena Group to Present at Noble Financial Conference
2. Chrome Group to Seek Listing for Some of its Subsidiaries
3. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
4. Reed Group to Provide MDA Internet Disability Duration Guidelines to U.S. Navy
5. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
6. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
7. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Completion of $2,277,000 Equity Financing
8. ThirdBiotech Networking Group Launches
9. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operating Officer
10. Reed Group Ltd. Announces Enterprise License for New Zealands Accident Compensation Corporation
11. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
Post Your Comments:
Related Image:
BIT Group Executive Featured in BioTechnology Series 
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... 23, 2016 Andrew ... Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
(Date:6/23/2016)... San Francisco, CA (PRWEB) , ... June 23, ... ... capture (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase ... DIA Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting ...
(Date:6/23/2016)... Connecticut (PRWEB) , ... June 23, 2016 , ... ... introduce a new line of intelligent tools designed, tuned and optimized exclusively for ... September 12–17 in Chicago. The result of a collaboration among several companies with ...
Breaking Biology Technology:
(Date:5/12/2016)... -- , a brand of Troubadour Research ... the Q1 wave of its quarterly wearables survey. A ... to a program where they would receive discounts for ... "We were surprised to see that so ... , CEO of Troubadour Research, "primarily because there are ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
Breaking Biology News(10 mins):